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Abstract
Magnetic resonance imaging (MRI) can be used to monitor pathological changes in Alzheimer’s disease (AD). The objective
of this longitudinal study was to assess the effects of progressive amyloid-related pathology on multiple MRI parameters in
transgenic arcAb mice, a mouse model of cerebral amyloidosis. Diffusion-weighted imaging (DWI), T1-mapping and
quantitative susceptibility mapping (QSM), a novel MRI based technique, were applied to monitor structural alterations and
changes in tissue composition imposed by the pathology over time. Vascular function and integrity was studied by
assessing blood-brain barrier integrity with dynamic contrast-enhanced MRI and cerebral microbleed (CMB) load with
susceptibility weighted imaging and QSM. A linear mixed effects model was built for each MRI parameter to incorporate
effects within and between groups (i.e. genotype) and to account for changes unrelated to the disease pathology. Linear
mixed effects modelling revealed a strong association of all investigated MRI parameters with age. DWI and QSM in addition
revealed differences between arcAb and wt mice over time. CMBs became apparent in arcAbmice with 9 month of age; and
the CMB load reflected disease stage. This study demonstrates the benefits of linear mixed effects modelling of longitudinal
imaging data. Moreover, the diagnostic utility of QSM and assessment of CMB load should be exploited further in studies of
AD.
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Introduction
Alzheimer’s disease (AD) has a complex pathophysiology with
pathomorphological hallmarks of the disease being the misfolding
of amyloid-b (Ab) protein and hyperphosphorylation of the tau
protein. These pathological changes are associated with the
aggregation of Ab plaques, neurofibrillary tangles, neuronal
degeneration and neuroinflammation [1]. In addition, cerebro-
vascular dysfunction has been implicated in the etiology of the
disease [2,3]. Transgenic mouse models have been engineered to
investigate the pathophysiology of AD [4,5], where several mouse
lines express the mutant genes for human amyloid precursor
protein (APP) and presenilin, responsible for the proteolytic
processing of APP. These transgenic mice develop Ab aggregates
(senile plaques) in the brain parenchyma in an age-dependent
manner. Some strains show a variable degree of Ab deposition at
the cerebral vasculature and vasculopathy [6]. Despite the fact that
transgenic mouse models do not completely replicate AD, they
have become indispensible for studying disease mechanism and
drug discovery.
Over the past years, a number of studies have emerged that use
magnetic resonance imaging (MRI) for the phenotyping of
transgenic mouse models of AD [7,8]. Anatomical scans have
demonstrated increased rates of brain atrophy in transgenic mice
compared to wild type (wt) mice [9,10]; and pathological
alterations in brain connectivity [11]. Diffusion-weighted imaging
(DWI) [12–14] and MR relaxometry [15–18] have revealed
regional changes in tissue microstructure and composition. In
addition, cerebrovascular dysfunction is characterized by cortical
hypoperfusion [19,20], reduced vascular reactivity [21], and the
occurrence of cerebral microbleeds (CMBs) [22]. While MRI
enables repetitive assessment of an animal and thus allows
following an MRI parameter over the course of the disease, most
studies were conducted as cross-sectional studies involving two or
more age groups. There are only very few longitudinal studies
[9,17], although such a study design can increase statistical power
by reducing the confounding effects of between-subject variability
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compared to cross-sectional studies [23]. Moreover, longitudinal
studies can establish the dynamics of a parameter over the disease
course, an important feature to evaluate the prognostic value of a
parameter. Common problems in longitudinal studies are missing
data due to drop-outs and non-uniform timing [17,24], which
significantly hampers the ability to draw the trajectories of
parameters for individual animals. Hence, standard statistical
analysis of longitudinal data like repeated measures ANOVA and
cross-sectional (General Linear Model based) analysis of summary
measurements cannot be used as they require balanced data sets
[24]. Recently, linear mixed effects (LME) modelling has been
proposed for the analysis of longitudinal studies where data sets
can be unbalanced with regard to the measurement time [24,25].
Moreover, this statistical approach can account for (several) effects
unrelated to the disease pathology which cannot be performed
with conventional statistical tests.
In the current study, we longitudinally assessed the effects of
progressive amyloid-related pathology on multiple MRI parame-
ters in transgenic arcAb mice, a mouse model of cerebral
amyloidosis [26], and used LME modelling for MRI data analysis.
The arcAb mouse develops age-dependent Ab accumulation in
the brain parenchyma as well as at cerebral vessels [6,20,22,26],
which makes it an ideal model to follow changes in structural
integrity and vascular function induced by the Ab pathology with
MRI. Changes in tissue composition and structural alterations
were monitored with DWI and T1-mapping. In addition to these
established techniques, we applied quantitative susceptibility
mapping (QSM), a novel technique that analyzes phase shifts
caused in the MRI signal by local changes in magnetic
susceptibility [27–29]. To assess impairment of blood-brain barrier
(BBB) integrity, we applied dynamic contrast-enhanced MRI
(DCE-MRI). CMB load, as a sign of severe vascular dysfunction,
was assessed with susceptibility weighted imaging (SWI) [30,31]
and QSM, as paramagnetic heme-iron leads to pronounced local
changes in the magnetic susceptibility. In this study, we found that
factors unrelated to the disease pathology have a strong effect on
all MRI parameters and that LME modelling can account for
these factors.
Materials and Methods
Animals and study design
All procedures conformed to the national guidelines of the Swiss
Federal act on animal protection and were approved by the
Cantonal Veterinary Office Zurich (Permit Number: 172–2008).
Transgenic arcAb mice and wt littermates of either gender
(Division of Psychiatry Research, University of Zurich) were used.
Animals were kept at standard housing conditions (temperature
20–24uC, relative humidity minimum 40%, light/dark cycle 12 h)
with water and food being provided ad libitum. Animals were
assessed serially from 5 to 21 months of age, where a first batch of
animals entered the study at 5 months of age and a second batch at
15 months of age (see Table 1). Each scan session consisted of two
sets of measurements using MRI systems of different field strength:
anatomical reference data, DWI, T1-mapping and DCE-MRI
data were acquired at 4.7 T, whereas anatomical reference and
gradient recalled echo (GRE) data were collected at 9.4 T for
computing GRE magnitude images, SWI and QSM; taking
advantage of the increased signal-to-noise ratio at the higher
magnetic field strength. Anatomical reference images were used
for planning of subsequent image acquisitions. Between the two
assessments animals had one week of recovery. When animals
needed to be euthanized after scanning, brains were collected for
Ab immunohistochemistry. The number of brains that were
investigated with histology were n= 2 (scan1), n = 1 (scan2), n = 4
(scan 3), and n= 1 (scan5), respectively.
MRI hardware and animal preparation
The first set of measurements were acquired on a Bruker
PharmaScan 47/16 (Bruker BioSpin GmbH, Ettlingen, Germany)
operating at 4.7 T and equipped with a volume resonator
operating in quadrature mode for excitation and a four element
phased array surface coil for signal reception. Anesthesia was
induced using 3% isoflurane (Abbott, Cham, Switzerland) in a 4:1
air/oxygen mixture. During MRI mice were spontaneously
breathing under isoflurane anesthesia (1.5%).
The second set of measurements were acquired on a Bruker
BioSpec 94/30 (Bruker BioSpin GmbH) small animal MR system
operating at 9.4 T. The system was equipped with a cryogenic
quadrature RF surface probe (Bruker BioSpin AG, Fa¨llanden,
Switzerland). Mice were endotracheally intubated and mechani-
cally ventilated during measurements with 90 breaths/minute
while applying a respiration cycle of 25% inhalation and 75%
exhalation (MRI-1 Volume Ventilator, CWI Inc., Ardmore, USA)
using 1.2% isoflurane. Fieldmap-based shimming was performed
using the automated MAPshim routine to reduce field inhomo-
geneities.
During both scan sessions body temperature was monitored
with a rectal temperature probe (MLT415, ADInstruments,
Spechbach, Germany) and kept at 36.060.5uC using a warm-
water circuit integrated into the animal support (Bruker BioSpin
GmbH).
Table 1.
scan1 scan2 scan3 scan3 scan4 scan4 scan5 scan5
batch1 batch1 batch1 batch2 batch1 batch2 batch1 batch2
group size
wt 11 10 10 8 8 5 6 4
arcAb 13 11 10 7 5 3 4 2
age*
wt 4.860.4 9.460.4 13.360.4 15.061.1 17.760.4 18.460.1 21.160.5 22.060
arcAb 4.860.4 9.760.4 13.460.2 14.961.2 17.860.01 18.460.03 21.260.2 21.960.04
*at entering first assessment of each scan session; values are given as mean6SD.
doi:10.1371/journal.pone.0066097.t001
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Sequence parameters for the first set of measurements
performed at 9.4T
(1) Anatomical reference data were acquired by applying a spin-
echo (SE) sequence (Rapid Acquisition with Relaxation
Enhancement [RARE]) with TE/TR= 38.6/4200 ms,
RARE factor = 8, in axial, sagittal and horizontal direction,
without averaging. Fifteen 0.5-mm thick slices with an
interslice distance of 0.6 mm were imaged with a field of
view (FOV) of 2 cm62 cm and a matrix size of 3846384,
resulting in a nominal voxel size of 52 mm652 mm. The
acquisition time was 3 min and 21 s for each direction.
(2) A 3D velocity compensated GRE sequence with TE/
TR=12/250 ms, a=15u, and no averaging was applied. A
horizontal slab was acquired covering a FOV of
1.5 cm61.2 cm62.2 cm with matrix dimensions of
2486199636, resulting in an isotropic resolution of
60 mm660 mm660 mm. The acquisition time was 29 min
51 s. Based on these GRE data magnitude images, SWI and
QSM have been computed and analyzed.
Sequence parameters for the second set of
measurements performed at 4.7T
(1) Anatomical reference data were acquired at 4.7 T by applying
a SE sequence (RARE) with TE/TR=33/2500 ms, RARE
factor = 8 in axial, and sagittal direction, without averaging,
for planning of subsequent image acquisitions. Nine 1-mm
thick slices with an interslice distance of 1.3 mm were imaged
with a FOV of 2 cm62 cm and a matrix size of 2006200,
resulting in a nominal voxel size of 100 mm6100 mm. The
acquisition time was 1 min and 2 s for each direction.
(2) For DWI, a four-shot SE echo planar imaging (SE-EPI)
sequence with TE/TR=29.4/3000 ms was used, starting
with 4 dummy scans. Ten 1-mm thick slices with an interslice
distance of 1.5 mm were acquired with a FOV of
3.29 cm62 cm and a matrix size of 1286128, resulting in a
nominal voxel size of 257 mm6156 mm. Diffusion-encoding
was applied in x-, y- and z-direction (gradient pulse duration
= 7 ms, gradient pulse separation = 14 ms) with b-values of
100, 200, 400, 600, 800, and 1000 s/mm2, respectively. The
total acquisition time was 3 min 48 s.For T1 mapping, six sets
of inversion recovery images were collected using multiple SE
sequences with slice selective RF pulses. Inversion times were
90.3, 150, 500, 1000, 3000, and 5500 ms. Imaging param-
eters were: TE= 8.2 ms, 3 averages and a RARE factor = 2.
The acquisition time was 15 min 21 s.
(3) For DCE-MRI a fast low angle shot (FLASH) sequence with
TE/TR: 4.6/12 ms, a=15u and 3 averages was repeated 300
times. Gd-DOTA (Dotarem, Guerbet, Paris, France) was
injected intravenously as a 50 ml bolus (2000 ml/min) after the
50th repetition. For both T1-mapping and DCE-MRI a single
axial slice of 2 mm with a FOV of 2 cm62 cm and a matrix
size of 80680 was acquired, resulting in an in-plane resolution
of 250 mm6250 mm. The acquisition time was 14 min 24 s.
Immunohistochemistry
Tissue preparation, immunohistochemistry protocol, and mi-
croscopy were performed as described previously [22]. As a
primary antibody a mouse anti-human Ab1–17 monoclonal
antibody (clone 6E10, SIG-39320, 1:2000, Covance, Princeton,
NJ, USA) and as a secondary antibody a goat-anti-mouse antibody
(Jackson ImmunoResearch Laboratories Inc., Suffolk, GB,1:500)
were used.
Selection of regions-of-interest
Regions-of-interest (2D; ROIs) were drawn on the parametric
maps by a person blinded to the genotype. In quantitative
susceptibility maps volumes-of-interest (3D; VOIs) where drawn,
excluding CMBs. Where applicable, olfactory bulb (ob), cerebral
cortex (cortex), caudate putamen and lateral globus pallidus (cp/lgp),
hippocampus (hc), corpus callosum (cc), fimbria hippocampi
(fimbria) and ventricles (csf) were identified (Fig. 1) as described in
[32]. Mean values were calculated for 2D and 3D region. For the
cortex, cp/lgp, hc and fimbria, ROIs were also drawn in each
hemisphere separately and values were averaged. ROIs were in
general selected to cover regions that are affected early and
strongly by Ab deposition e.g. cortex and regions that were affected
later and to a lesser extent e.g. cp/lgp.
Data processing
Apparent diffusion coefficient (ADC) maps were computed from
diffusion-weighted images [33] using Paravision (Bruker BioSpin
MRI). The index of diffusion anisotropy (IDA) was calculated [34]
as:
IDA~ ADCmax{ADCminð Þ=ADCmean ð1Þ
where ADCmax corresponds to the maximum, ADCmin to the
minimum and ADCmean to the mean ADC value measured in
each selected ROI.
T1-maps were computed pixel-wise through a non-linear least-
squares fit [35]. DCE-MRI data analysis was performed as
described [36] with custom software written in MATLAB
(Mathworks, Natick, MA) and yielded the relative transfer
constant of Gd-DOTA from the plasma into extracelluar space,
Ktrans, and the relative volume of the extravascular extracellular
space, ve.
Quantitative susceptibility maps and SW images were comput-
ed from the GRE data. SW images were generated as described
previously [30,31]. For QSM, phase images were first unwrapped
using a 3D best-path algorithm [37] and background phase
contributions were eliminated with projection onto dipole fields
[38]. Brain tissue masks were generated, and applied for
background phase correction and removal of extracranial struc-
tures. Quantitative susceptibility maps were reconstructed from
the background-corrected phase images through Homogeneity
Enabled Incremental Dipole Inversion [29]. Magnetic susceptibil-
ity DxI of specific brain region I were calculated according to:
DXI~XROI ,I{XCSF
Since the calculated susceptibility values represent relative
rather than absolute values [39], susceptibility values were
specified as difference with respect to the magnetic susceptibility
measured in the ventricles. We have excluded Ab-related effects
on the magnetic susceptibility of the reference region by
performing an analysis of covariance between the values of
magnetic susceptibilities measured in the ventricles of arcAb and
wt mice. We found no significant differences between the slope
and the intercept of the two regression lines (F = 0.28, p = 0.59 and
F= 0, p = 1, respectively).
Logitudinal MRI of Amyloid Pathology
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Assessment of CMB load
CMBs were identified as round or ovoid lesions on horizontal
GRE magnitude and SW images (black lesions) as well as
quantitative susceptibility maps. Additional slices above and below
the slice of interest were viewed, to ensure that the suspected CMB
was confined and not a vessel cross-section. Each identified CMB
was encircled by a VOI. A template was generated from GRE
magnitude images by non-linear incremental registration using
advanced normalization tools [40]. CMBs were then superposed
onto the registration template image by applying the computed
affine registration matrices and deformation fields to each VOI of
the CMB with nearest neighbour interpolation. VOIs for each
sample volume were manually counted to estimate CMB load.
CMB load among groups was compared using Fisher’s exact test.
LME modelling of MRI data
Analysis was performed with the statistical computing environ-
ment R [41]. The LME model was fitted for each MRI parameter
(Y) according to:
yjklMi~genotypej(M)zgenderk(M)zbrainregioni
zbagezbj(age : genotype)z
bk(age : genderk)zbI(age : brainregionl)
zmouseMzejklMi
ð2Þ
mouseM ~N(0,v2),ejklMi ~N(0,d2) ð3Þ
where yjklMi represents the measurement i of MRI parameter Y
for mouse M with genotype j and gender k in brain region i. The
nested design (i.e. each mouse belongs to one genotype and has
one gender) is denoted by the functional index of M. The terms
genotypej(M), genderk(M) and brainregionl are the fixed effects of
genotype, gender and brain region which are assumed to be
identical for all mice. The coefficient b describes the slope in age.
Since the slope of time might depend on the brain region, gender
and genotype, we further included interactions (denoted with
colons, e.g. age*genotype). bj represents the interaction of the
slope in age by the genotypej,, bk by genderk, and bl by
brainregionl. The random effect mouseM represents the devia-
tion for each mouse M from the population mean. It is modelled as
normally distributed random variable and incorporates the
correlation of the repeated measurements in its variance. ejklMi
is the usual error term for observation i. Model assumptions were
checked by residual analysis (QQ-plot, Tukey-Anscombe-plot). To
identify differences in brain regions post hoc tests were performed.
In case of more than two brain regions, p-values were corrected by
the Bonferroni method. A value of p,0.05 was considered as
statistically significant.
Results
Characteristics of longitudinal data
The number of animals decreased over the course of the study
(Table 1). Animals whose physiological conditions were compro-
mised, e.g. due to spontaneous tumor development in aged mice,
had to be excluded. Moreover, each scan session (including animal
preparation and measurement) lasted about 1 hour, during which
animals were anesthetized. These anesthesia episodes also caused
drop-out of animals, in particular in aged mice. In addition,
missing data occurred as animals were not scanned due to
unforeseen problems in animal preparation or if data had to be
excluded due to insufficient quality.
A second characteristic of longitudinal data is the non-uniform
timing of assessments. Animals differ in age by a few days when
entering the study (Table 1), and hence are not assessed at exactly
the same time point. In addition, given the large number of
animals assessed at each scan session, measurements with an
individual set-up can take up more than one week, leading to
variations in the time intervals between scans for individual
animals.
A third characteristic of the data is the between-subject
variability of values of MRI parameters (Table S1).
LME modelling of structural MRI parameters
The results of the LME model analysis demonstrated that ADC
values of grey matter regions were significantly associated with
brain region, gender and age as well as interaction of genotype and
age (Table 2). Post hoc analysis revealed that the ADC values of hc
were significantly different from the ADC values of cp/lgp and ob,
but not from those observed in cortex (Table 3). The evolution of
ADC with age was significantly different between arcAb and wt
mice. (Fig. 2). While ADC decreased in different regions in wt
mice with increasing age, it stayed constant or even tended to
increase in arcAb mice (slope = 2861025 mm2/s per year in wt
vs 1.8961025 mm2/s per year in arcAb mice). IDA values of two
white matter regions were significantly associated with brain
region, and the interaction of genotype and age (Table 2). Values
were higher for fimbria compared to cc (Fig. 2, Table 3). Moreover,
for both regions IDA values developed differently in wt and arcAb
mice as a function of age. They slightly increased in wt mice, but
decreased in arcAb mice, indicating a loss of diffusion anisotropy
in the latter (slope = 0.0741 for wt vs slope = 20.3134 for arcAb
mice; Fig. 2).
Figure 1. Examples on region-of-interest (ROI) delineating different anatomical regions. T2-weighted spin echo images of the mouse
brain acquired at 9.4T in sagittal (A), axial (B–D) and horizontal (E) orientation. ROIs were identified for the olfactory bulb (ob), cerebral cortex (cortex),
caudate putamen and lateral globus pallidus (cp/lgp), hippocampus (hc), corpus callosum (cc), fimbria hippocampi (fimbria) and ventricles (csf).
doi:10.1371/journal.pone.0066097.g001
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T1 relaxation times were significantly different between cortex
and cp/lgp and revealed an association with age, but neither with
genotype nor the interaction of genotype with age (Table 2 and 3).
Trajectories of T1 values increased similarly in both groups over
time with (Fig. 2).
Magnetic susceptibility was found to be significantly associated
with brain region, age and genotype as well as the interaction of
genotype with age and gender (Table 2). Post hoc analysis revealed
that the values in cc and hc were significantly different from each
other and from those of all other brain regions (Table 3).
Susceptibility differences were lower for the cc and higher for the hc
compared to all other brain regions investigated. Magnetic
susceptibilities increased in different regions of the brain in both
groups with age, but the slope was smaller in arcAb mice
compared to wt mice (slope = 1.0461022 for male and slope
= 2.9261023 for female wt mice vs slope = 6.5261023 for male
and slope = 29.2161024 for female arcAb mice; Fig. 3).
LME modelling of vascular MRI parameters
Ktrans and ve values showed an association with age, but neither
with genotype nor interaction of genotype with age (Table 2).
Ktrans was also associated with brain regions were significant
different values were observed between cortex and cp/lgp (Table 3).
Ktrans increased with age, whereas ve decreased in all brain areas
evaluated (Fig. 3).
SWI and QSM have increased sensitivity for detecting CMBs
compared to conventional GRE magnitude images [22]. CMBs
were identified as round or ovoid lesions on horizontal GRE
magnitude and SW images (black lesions) as well as quantitative
susceptibility maps (Fig. 4A–C, white arrows). The load of
paramagnetic inclusions, attributed to CMBs, was markedly
higher in arcAb mice compared to wt mice (Table 4). Probable
CMBs were first observed in arcAb mice at 9 months of age,
whereas they became first evident in wt mice at 13 months. CMBs
were detected in 71% of arcAb mice at 18-month of age, but only
in 20% of wt mice (at 21 month of age). The total number of
CMBs detected in arcAb mice was significantly higher in arcAb
mice than in wt mice (p,0.001). CMBs were predominantly
observed in the cortex and ob, but were also seen in the hc (Fig. 4).
Age-dependent deposits of Ab plaques in arcAb mice
Immunohistochemical evaluation revealed an age-dependent
increase in Ab plaque deposition in arcAbmice (Fig. 5). Animals at
6 months of age were devoid of plaques, initial plaque formation in
Figure 2. Scatter plots of apparent diffusion coefficient (ADC), index of diffusion anisotropy (IDA) and T1 relaxation times as a
function of age for wild type (WT) and transgenic arcAb (ArcAb) mice. Cp/lgp denotes caudate putamen and lateral globus pallidus.
doi:10.1371/journal.pone.0066097.g002
Table 2. P-values of linear mixed effects model analyses of the MRI parameters.
ADC IDA T1 magnetic susceptibility K
trans ve
brain region 0.0002 ,0.0001 ,0.0001 ,0.0001 0.0473 0.1906
genotype 0.3913 0.9186 0.7974 0.0367 0.1822 0.3336
age 0.0157 0.3781 ,0.0001 ,0.0001 0.0112 0.0110
gender 0.0010 0.8306 0.5247 0.7041 0.1688 0.6203
brain region:age 0.7354 0.5539 0.1608 0.1305 0.7535 0.6826
genotype:age 0.0005 0.0023 0.5137 0.0159 0.1953 0.7049
gender:age 0.0619 0.5379 0.0570 0.0002 0.3443 0.6463
ADC values were determined for ob, cortex, cp/lgp, and hc. IDA values were estimated for the cc and fimbria. T1, K
trans and ve were estimated for the cortex and cp/lgp.
Magnetic susceptibility values were estimated for ob, cortex, cp/lgp, cc, and hc. Statistical significance is highlighted (bold).
doi:10.1371/journal.pone.0066097.t002
Table 3. Post hoc analysis assessing different values of
individual MRI parameters between brain regions.
MRI parameter p-value
ADC hc vs. cortex 0.1049
hc vs. cp/lgp 0.0011
hc vs. ob 0.0003
cortex vs. cp/lgp 0.9828
cortex vs. ob 0.4837
cp/lgp vs. ob 1.0000
IDA fimbria vs. cc ,0.0001
T1 cortex vs. cp/lgp ,0.0001
magnetic susceptibility cc vs. cortex ,0.0001
cc vs. cp/lgp ,0.0001
cc vs. hc ,0.0001
cc vs. ob ,0.0001
cortex vs. cp/lgp 1
cortex vs. hc 0.197
cortex vs. ob 1
cp/lgp vs. hc 0.022
cp/lgp vs. ob 1
hc vs. ob 0.104
Ktrans cortex vs. cp/lgp 0.0473
ve cortex vs. cp/lgp 0.1906
ADC values were determined for ob, cortex, cp/lgp, and hc. IDA values were
estimated for the cc and fimbria. T1, K
trans and ve were estimated for the cortex
and cp/lgp. Magnetic susceptibility values were estimated for ob, cortex, cp/lgp,
cc, and hc. Statistical significance is highlighted (bold).
doi:10.1371/journal.pone.0066097.t003
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neocortical areas became apparent at 7 months of age. Plaque
deposition increased until an age of 21 months and spread to
hippocampal, striatal, thalamic as well as to cerebellar and
brainstem regions.
Discussion
Characteristics of longitudinal MRI data
One of the main challenges of longitudinal studies is missing
data. Not all mice in our study have data on all 5 assessments. This
is either due to design of the study (one batch entered at scan
session 3) or due to premature demise of animals which becomes in
particular weighty towards the end of the study (Table 1) as aged
animals became increasingly fragile. In addition, a few animals
missed a particular measurement but were assessed during the
next scan session. Also data had to be excluded from the analysis
due to insufficient quality. A major drawback of missing data is
that conventional methods for statistical analysis e.g. repeated
measure ANOVA are not applicable i.e. it could be applied only to
few cases were 5 complete measurements are available for an
animal. Imputation methods for missing data have been developed
but they have limitations [42]. We have opted to use LME
modeling as a statistical framework because it draws trajectories
across a population rather than individuals and can account for
missing data [24,25]. Thus the number of animals per group
analyzed were n= 15 (wt) and n= 17 (arcAb) for ADC and IDA,
n= 15 (wt) and n= 17 (arcAb) for T1, n= 19 (wt) and n= 21
(arcAb) for magnetic susceptibility, and n= 15 (wt) and n= 15
(arcAb) for Ktrans and ve.
A second important feature of longitudinal data sets is that they
are unbalanced with regard to the measurement time. Animals
cannot be assessed at once within a single scan day. In fact, the
assessment of the first and last animal in a single scan session can
vary by as much as by two weeks. These variances in measurement
time also preclude the use of repeated measure ANOVA. In
contrast, LME model is suitable to handle such unbalanced data
sets [24,25].
In this study we used mice of the same strain with a controlled
genetic background. Hence, phenotypes were expected to be
homogenous. However, we observed a high degree of between-
subject variability of investigated MRI parameters (Table S1).
Factors such as age, gender and environment have been reported
to affect the phenotype [43]. While some of these factors can be
controlled for e.g. breeding and housing conditions of mice, other
factors (keeping single mouse in cage vs. housing in groups,
individual degrees of physical exercise, fighting among animals,
comorbidities etc.) cannot be controlled and might thus account
for the observed variability.
Figure 3. Scatter plots of Ktrans, ve and magnetic susceptibility as a function of age for of wild type (WT) and arcAb (ArcAb) mice. Cp/
lgp denotes caudate putamen and lateral globus pallidus.
doi:10.1371/journal.pone.0066097.g003
Figure 4. Horizontal GRE magnitude images, susceptibility weighted images and quantitative susceptibility maps of a 21 month
old arcAb mouse. Suspected microbleeds are indicated by white arrows, while structures corresponding to vessel cross-sections are indicated by
red arrows. The scale bar indicates 1 mm. Topography of cerebral microbleeds (CMBs) of a an arcAb mouse with high CMB load at 13 (A), 18 (B) and
21 (C) months of age. Average projections of the registration template over an acquired slab of 2.1 mm thickness. The brain regions affected are
predominantly the cortex and olfactory bulb and to a lesser extent the hippocampus. The CMB load increases with increasing age. The frequency of
overlapping CMBs in 3D assessed at a single time point is indicated by the colour bar.
doi:10.1371/journal.pone.0066097.g004
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LME modelling reveals effects unrelated to disease
pathology
In the LME model we have included the parameters brain
region, gender and age as fixed variables to account for changes
unrelated to disease pathology. The analysis revealed that almost
all parameters, except ve, depended on the brain regions. This is
not surprising, given that the cellular morphology, myo- and
cytoarchitecture, water content and diffusivity, concentration of
minerals, vascular density, and metabolic activity of the brain are
known to differ between anatomical regions. In addition, the
analysis revealed an effect of gender on ADC and an interaction of
age and gender on magnetic susceptibility. While sexual dimor-
phism of the mouse brain has been reported for volumes of certain
brain structures [44] it was not known to what extent it might
affect the MRI parameters investigated in this study. To date, most
MRI studies using mice have not looked for differences between
gender and often do not even report whether male, female or mice
of both genders were used.
Our analysis revealed that aging had significant effects on all
parameters investigated, except IDA. Aging leads to changes in
tissue structure and composition as well as vascular function [45–
48]. These changes clearly affect the MRI parameter under study
and in fact the mechanism of these changes might resemble those
seen during pathological states. Hence, imaging approaches need
to be capable to identify pathological changes from age-related
processes.
LME model demonstrates an effect of pathology on
water diffusivity and magnetic susceptibility over time
Subsequently, we used LME modelling of data to reveal which
parameters were significantly different in arcAb mice compared to
wt mice. An effect of genotype was observed only on magnetic
susceptibility. But accepting the interaction of age and genotype,
the structural parameter ADC, IDA and magnetic susceptibility
were significantly different in arcAb mice compared to wt mice.
Previous studies have reported changes in water diffusivity in the
brain of transgenic mice. Decreased ADC values were observed in
APP23 mice compared to age-matched wt controls [12,13], while
a study in TgCRND8 mice found no significant changes of ADC
in the hc and cortex [14]. Mueggler et al. found ADC values in
cortex and striatum of 6 month old APP23 mice ADC to be
between 5.4760.25 and 6.9160.22 and 5.9060.196106 cm2/s,
respectively [12]. In the cortex and striatum of 25 months old
APP23 mice ADC values were found to be between 5.0960.33
and 6.8660.34 and 5.7960.436106 cm2/s for, respectively.
Sykova et al. reported ADC values to be between 5.9660.07
and 5.9760.156106 cm2/s in the brains of 6–8 month and
between 5.7460.09 and 5.8960.036106 cm2/s in the brains of
17–25 months old male and female APP23 mice, respectively [13].
White matter regions were not assessed in these studies. These
findings are clearly in contrast to our study where an increase in
grey matter ADC values and a decrease in IDA values were
observed in arcAb mice (Fig. 2). Moreover, ADC values were with
8.2261.36 and 8.2362.396106 cm2/s in the cortex and cp/lpg of 5
month old arcAb mice generally higher than those reported for
Table 4. Occurrences of cerebral microbleeds (CMBs).
wt arcAb
age [months] animals animals with CMBs CMBs/mouse (95% CI) animals animals with CMBs CMBs/mouse (95% CI)
scan 1 9 0 0 11 0 0
scan 2 8 0 0 6 2 1 (1)
scan 3 17 1 2 16 10 9 (4–14)
scan 4 10 2 2 (0–8) 7 5 26 (0–65)
scan 5 5 1 2 3 1 96
CMBs were identified from GRE magnitude images, susceptibility weighted images and quantitative susceptibility maps. The number of animals, the incidence (animals
with CMBs) and mean number of CMBs, 95% confidence interval (CI) per affected mouse detected in wild type (wt) and transgenic arcAb mice at different ages.
doi:10.1371/journal.pone.0066097.t004
Figure 5. Age-dependent accumulation of Ab plaques in arcAb
mice. Anti-Ab immunohistochemical staining of sagittal brain sections
at 5, 9, 13, 18 and 21 months of age. Right panels show normalized
colour-coded images depicting the strongest signals in yellow and
background in dark blue. Animals at 6 months of age were devoid of
plaques, initial plaque formation in neocortical areas became apparent
at 7 months of age. Plaques rapidly increase in number between 13 and
21 months of age, affecting hippocampus as well as striatal and
thalamic areas. Late stages also included plaque deposition in the
cerebellum and brainstem areas. The scale bar indicates 1 mm.
doi:10.1371/journal.pone.0066097.g005
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APP23 of similar age (Table S1). Similarly, ADC values were
8.2160.65 and 7.8360.50 in the cortex and cp/lpg of 21 month old
arcAb mice and thus higher as the reported values in APP23 mice.
The differences in values might be explained in parts by
differences in methodology since we have also observed higher
ADC in the brains of wt mice. However, water diffusivity might
differ among different transgenic mouse lines and at different ages.
The observed lack of differences in ADC values between 12–16
month old TgCRND8 mice [14] and 6–8 month old APP23 mice
[12,13] and age matched controls might be a consequence of still
relatively mild amyloid pathology. On the other hand, the
observation of reduced ADC values in 25 month old APP23
animals might represent an effect of end-stage pathology (an age
which we have not assessed in arcAb mice). All of those studies
were performed in cross-sectional design comparing two age
groups (though some of them spanning several months of age) and
thus the reported differences represent only a snapshot or averages
of values. Information about how a parameter has evolved in-
between or after an early assessment is missing. Using longitudinal
data we observed unchanged or slightly increasing ADC values in
arcAb mice between 5 and 21 month of age. In future studies we
would use diffusion tensor imaging which information about the
fractional anisotropy in addition to the diffusion coefficient.
Studies have also examined the effect of amyloid-related
pathology on the tissue relaxation times of the brain. While
Helpern et al. have found no differences in T1 values between
different brain regions of 16–23 month old APP/PS1 and PS1 and
non-transgenic controls [15], El Tannir El Tayara et al. reported a
significant differences between the brain of APP/PS1 and PS1
mice when measured over time from 27 to 86 weeks of age [16].
T1 values were approximately 1275 ms in the cortex and 1285 ms
in the striatum of 28 week old APP/PS1 mice and decreased to
approximately 1210 ms and 1190 ms in the cortex and striatum in
80 weeks old APP/PS1 mice, respectively. T1 values in the study of
Helpern et al. were not given. In 5 month old mice arcAb mice we
measured T1 values of 14646478 and 12266400 ms for the cortex
and cp/lgp, respectively (Table S1), thus being similar to reported
values. T1 increased to 16036616 and 13226506 ms for the cortex
and cp/lpg of 21 month old arcAb mice, respectively. However, T1
values increased also in wt mice and we observed no differences
between genotypes. The difference in T1 among different mouse
strains might be explained by the fact that plaques in APP/PS1
mouse brains contain iron [15] leading to decreases in T1 of the
tissue with accumulation of plaques. In contrast, cortical and
subcortical plaques in the arcAb mice contain no iron [22]. Thus,
plaque deposition does not seem to affect T1.
Effects of amyloid-related pathology on vascular function
As vascular pathology has been implicated to partake in the
pathogenesis of the disease, we have additionally used MRI
techniques which are sensitive to changes in vascular function.
The arcAb mouse strain used, which expresses both the Swedish
and Arctic APP mutations [26], shows both amyloid-related
changes in brain parenchyma and at the cerebral vasculature. In
this strain Ab deposition starts at around 7 months of age and is
not only confined to the brain parenchyma but occurs also at
cerebral blood vessels [6,26]. Ab deposition starts in the cerebral
cortex and then spreads to the dorsal and ventral areas of the brain
with age (Fig. 3; [26]). Ab deposition is accompanied by
astrogliosis in particular surrounding diffuse Ab plaques in the
neutropil and around CAA-affected vessels [6]. Vascular pathol-
ogy related to amyloid is pronounced and includes changes in
vessel morphology, impairment of vascular reactivity, vascular
fibrinogen deposition and vessel stenosis, neurovascular uncou-
pling, loss of vascular smooth muscle cells with BBB leakage and
the occurrence of CMBs [6,20–22].
We have probed BBB integrity and occurrence of CMBs in
arcAb mice with MRI. Using DCE-MRI we did not find signs of
evident BBB leakage which is surprising as a compromised BBB
integrity of Ab-affected vessels has been described for this mouse
strain, detecting the extravasation of a vascular fluorescent marker
[6]. One explanation might be that BBB dysfunction in AD is
more subtle compared to diseases such as brain tumors, multiple
sclerosis and stroke, for which the impairment is relatively large
and focal [49]. Hence, in contrast to histological techniques DCE-
MRI may not be sufficiently sensitive to detect BBB impairment in
mouse models of AD in-vivo.
We have shown previously that GRE imaging can be applied to
non-invasively detect CMBs in the mouse brain [22]. CMBs were
found to occur frequently with age in arcAbmice. Studies have also
demonstrated that CMBs also occur in other mouse strains like
APP23 and Tg2576 mice [50,51]. CMB incidence and load
increased between 9 and 18month of age (Table 4), but drop-outs of
animals during the study render it difficult to judge how this
progressed beyond 18 month of age. We found the CMBs mainly
affected ob, cortex and hc. However, due to time constraints associated
with high spatial resolution measurements (60 mm isotropic voxels)
the assessment of CMBs was limited to a 2.2 mm slab covering
essentially cortical structures only. Hence, we cannot make a
statement regarding the incidence of CMBs in more basal brain
areas. Given that the incidence of CMBs in arcAb mice was
between 33 and 71% during 9 to 18 month while they were 0 to
20% in wt mice during the same age span, it appears that detection
of CMB load is a sensitive indicator of vascular pathology.
The limitations of using MRI for detecting amyloid-
related pathology in transgenic mouse models of AD
We have found a significant interaction of age and genotype for
QSM and DWI, both techniques may be associated with
pathological changes in tissue structure and composition. It is
known that many processes such as glia activation, de- and
remyelination and impairment of membrane integrity can affect
water diffusivity and magnetic susceptibility [33,52], but it was not
the purpose of this study to evaluate the contrast mechanism
underlying the changes in these parameters in the arcAb mouse
brain. Such studies would have required sacrificing animals after
MRI measurement in order to perform biochemical analysis and
histology of the brain, which was precluded in the longitudinal
design chosen. Moreover, since water diffusion and tissue
magnetic susceptibility are affected by a variety of processes/
sources which change the biophysical properties of the tissue, these
methods will never be entirely specific for a pathological process
but rather reflect the sum of microstructural changes occurring in
the tissue. Only in the best case the values are governed by a single
dominating mechanism.
Conclusions
MRI studies of transgenic mouse models are affected by
variability of disease phenotype, making the detection of subtle
and slowly developing effects of pathology on MRI parameter
challenging. Under these conditions, a longitudinal study design
where data is pooled across the study population enables the
identification of changes in MRI parameters that can be attributed
to the pathology. LME modelling is a suitable framework for
analyzing longitudinal data sets as it accounts for confounders
unrelated to AD pathology which cannot be easily controlled for in
such studies.
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